Epidemiology of nonmelanoma skin cancer (NMSC) in Europe
Actinic keratosis is an early in situ squamous cell carcinoma
Actinic keratoses
Apoptosis pathways as promising targets for skin cancer therapy
The role of apoptosis in therapy and prophylaxis of epithelial tumours by nonsteroidal anti-inflammatory drugs (NSAIDs)
Low prevalence of p53, p16INK4a and Ha-ras tumour-specific mutations in low-graded actinic keratosis
Treatment of multiple actinic keratoses with topical diclofenac 3% gel in organ transplant recipients
Management of actinic cheilitis using diclofenac 3% gel
Differentiation between actinic keratoses and disseminated superficial actinic porokeratoses with reflectance confocal microscopy
Does progression from actinic keratosis and Bowen's disease end with treatment
Genetically determined susceptibility to COX-2 inhibitors – a report of exaggerated responders to diclofenac 3% gel in the treatment of actinic keratoses